Top compounds associated with response to DEFB130


Feature Type Standardized
Nominal ANOVA
mRNA navitoclax:sorafenib (1:1 mol/mol) CTRPv2 pan-cancer AAC -0.048 0.2
mRNA AT7867 CTRPv2 pan-cancer AAC -0.048 0.2
mRNA 3-Cl-AHPC CTRPv2 pan-cancer AAC -0.046 0.2
mRNA CAY10618 CTRPv2 pan-cancer AAC 0.047 0.2
mRNA indisulam CTRPv2 pan-cancer AAC -0.044 0.2
mRNA lapatinib UHNBreast pan-cancer AAC -0.41 0.2
mRNA SU11274 CTRPv2 pan-cancer AAC -0.047 0.2
mRNA alisertib CTRPv2 pan-cancer AAC -0.042 0.2
mRNA BRD9876 CTRPv2 pan-cancer AAC -0.051 0.2
mRNA navitoclax:pluripotin (1:1 mol/mol) CTRPv2 pan-cancer AAC -0.048 0.2
Download CSV